The M-S DRG100 is a cutting-edge pharmaceutical granulation machine that addresses the critical pain points of conventional granulation methods. With its innovative double rolle design and advanced features, it empowers pharmaceutical manufacturers to achieve unmatched levels of granulation efficiency, product quality, and cost-effectiveness.
The M-S DRG100's revolutionary double rolle technology sets it apart from traditional granulators. The unique design features two counter-rotating rollers that apply pressure and shear force to the powder blend, resulting in exceptional granulation uniformity and narrow particle size distribution. This precision engineering ensures consistent product quality, reduced waste, and improved down-stream processing.
The M-S DRG100's versatility empowers manufacturers to explore novel applications and identify new product opportunities. From innovative pharmaceutical formulations to advanced drug delivery systems, the possibilities are limitless.
Model: M-S DRG100
Capacity: 100 kg/hr
Roller Diameter: 150 mm
Roller Width: 200 mm
Speed Range: 5-25 rpm
Pressure Range: 0-10 bar
Power Supply: 220 V, 3-phase, 50/60 Hz
Dimensions: 1000 mm x 500 mm x 1200 mm (L x W x H)
Weight: 250 kg
The M-S DRG100 magnesium silicate double rolle granulator machine is a game-changer in pharmaceutical manufacturing. Its innovative technology, advanced features, and proven performance address the critical pain points of conventional granulation methods, empowering pharmaceutical manufacturers to achieve unprecedented levels of efficiency, product quality, and cost-effectiveness.
Table 1: Comparison of Granulation Efficiency
Method | Granulation Efficiency |
---|---|
Conventional Granulation | 60-70% |
M-S DRG100 | 90-95% |
Table 2: Energy Consumption Comparison
Method | Energy Consumption (kWh/kg) |
---|---|
Conventional Granulation | 0.5-1.0 |
M-S DRG100 | 0.2-0.5 |
Table 3: Effect on Production Costs
Factor | Conventional Granulation | M-S DRG100 |
---|---|---|
Granulation Efficiency | Lower | Higher |
Waste | Higher | Lower |
Energy Consumption | Higher | Lower |
Total Production Costs | Higher | Lower |
Table 4: Novel Applications for the M-S DRG100
Application | Description |
---|---|
Controlled Drug Delivery | Granulation of drugs dispersed in polymers to achieve sustained release |
Targeted Drug Delivery | Granulation of drug-loaded nanoparticles to target specific organs or tissues |
Taste Masking | Granulation of bitter or unpleasant-tasting drugs to improve patient compliance |
2024-11-17 01:53:44 UTC
2024-11-18 01:53:44 UTC
2024-11-19 01:53:51 UTC
2024-08-01 02:38:21 UTC
2024-07-18 07:41:36 UTC
2024-12-23 02:02:18 UTC
2024-11-16 01:53:42 UTC
2024-12-22 02:02:12 UTC
2024-12-20 02:02:07 UTC
2024-11-20 01:53:51 UTC
2024-09-24 09:28:34 UTC
2024-09-24 09:28:37 UTC
2024-09-26 15:58:10 UTC
2024-09-26 15:58:29 UTC
2024-09-27 14:16:57 UTC
2024-09-28 18:22:28 UTC
2024-09-28 18:22:46 UTC
2025-01-08 06:15:39 UTC
2025-01-08 06:15:39 UTC
2025-01-08 06:15:36 UTC
2025-01-08 06:15:34 UTC
2025-01-08 06:15:33 UTC
2025-01-08 06:15:31 UTC
2025-01-08 06:15:31 UTC